Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on discovery and development and subsequent commercialization of novel first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases.
The Sr. Specialist – Analytical Chemistry will participate in the analytical method development, validation, and transfers at the clinical stage. The individual is also responsible for the analytical review of methods, protocols, and reports for validation and stability studies. Assist in preparation and review of regulatory filings from early development to commercialization. The individual will also manage CMOs and CROs to meet the program timelines and objectives.